Our previous studies using gene delivery of IL-27 significantly reduced the rate of tumor growth and normalized in vivo bone density [4], potentially through recruitment of immune effectors to tumors; however, mechanisms by which IL-27 can promote direct effects on tumor cells remains incompletely characterized. This evidence concerns the gene IL27 and neoplasm.